Evidence map›Paper›PMID 42294858›Full record

ArticleInternational journal of urology : official journal of the Japanese Urological Association2026

Multi-Center, Real-World Registry Study of the UroLift Prostatic Urethral Lift (PUL) for Benign Prostatic Hyperplasia (BPH) in Japan.

Naoya Masumori, Satoru Takahashi, Go Anan, Fumiyasu Endo, Akira Furuta, Kazunori Haga, Mina Hatanaka, Shinobu Kato, Yoshihiro Komai, Yuki Kyoda and 6 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of urology : official journal of the Japanese Urological Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Naoya MasumoriDepartment of Urology, Sapporo Medical University, Sapporo, Hokkaido, Japan.ORCID https://orcid.org/0000-0001-6324-0739
Satoru TakahashiDepartment of Urology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Go AnanDepartment of Urology, Yotsuya Medical Cube, Chiyoda-ku, Tokyo, Japan.
Fumiyasu EndoDepartment of Urology, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2879-2727
Akira FurutaDepartment of Urology, Jikei University School of Medicine, Minato-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0001-7426-6395
Kazunori HagaDepartment of Urology, Sanjukai Urological Hospital, Sapporo-shi, Hokkaido, Japan.ORCID https://orcid.org/0009-0001-7618-6783
Mina HatanakaUrology, Saitama Sekishinkai Hospital, Sayama-shi, Japan.
Shinobu KatoKato Urological Clinic, Hiratsuka-shi, Kanagawa, Japan.
Yoshihiro KomaiKomai Nephrology and Urology Clinic, Osaka-shi, Osaka, Japan.
Yuki KyodaDepartment of Urology, Sapporo Medical University, Sapporo, Hokkaido, Japan.
Nayuka MatsuyamaDepartment of Urology, Inuyama Chuo General Hospital, Inuyama-shi, Aichi, Japan.
Shinichiro MurayamaUrology Department, Tokyo International Ohori Hospital, Mitaka-shi, Tokyo, Japan.
Hirotaka NagamatsuOita Urology Hospital, Oita-shi, Oita, Japan.
Daisuke ObinataDepartment of Urology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0002-8584-4506
Zenkichi SekiguchiDepartment of Urology, St. Marianna University Yokohama Seibu Hospital, Yokohama-shi, Kanagawa, Japan.
Yuma WasedaDepartment of Urology, Institute of Science Tokyo, Bunkyo-ku, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe prostatic urethral lift (PUL) for benign prostatic hyperplasia (BPH) has been shown to deliver rapid, durable symptom relief with low morbidity. Most studies have been performed in Western populations. The objective was to understand how PUL performs in the real world in Japan among a broad patient population.

methodsA post-market registry study of consecutive PUL subjects across 14 Japanese centers was conducted. International Prostate Symptom Score (IPSS), quality of life (QOL), maximum flow rate (Q

results210 subjects were included. Baseline characteristics included age 74.3 ± 8.5 years, IPSS 18.0 ± 7.4, QOL 4.8 ± 1.3, Q

conclusionsThis registry study from Japan indicates PUL is safe and effective; results corroborate those of previous studies. The data support the use of PUL in the broader BPH population in Japan.

trial registrationJapan Registry of Clinical Trials (jRCT 2032220377).

Indexed as

Lower Urinary Tract SymptomsProstatic HyperplasiaUrethraAgedAged, 80 and overHumansJapanMaleMiddle AgedProduct Surveillance, PostmarketingProstateQuality of LifeRegistriesTreatment Outcomebenign prostatic hyperplasiaJapanlower urinary tract symptomsminimally invasive surgeryreal world clinical trials

Identifiers

PMID42294858
PMCPMC13267450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.